Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
No open-market purchases or sales by Medicinova Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Medicinova Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q2 2025
- Shares held
- 5.13M
- −42.8K (−0.8%) vs. Q2 2025
- Total value
- $6.49M
- −$286.0K (−4.2%) vs. Q2 2025
- New holders
- 4
- 7 more added
- Sold out
- 1
- 6 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 6 | $0 | 0.00% | +6 | New |
| FMR LLC | 50 | $63 | 0.00% | +50 | New |
| JPMorgan Chase & Co | 76 | $96 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 305 | $387 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,000 | $2.54K | 0.00% | +2,000 | New |
| Tower Research Capital LLC (TRC) | 2,209 | $2.81K | 0.00% | −1,253−36.2% | Reduced |
| Hantz Financial Services, Inc. | 4,300 | $5.00K | 0.00% | 00.0% | Unchanged |
| Schonfeld Strategic Advisors LLC | 34,650 | $44.0K | 0.00% | −100−0.3% | Reduced |
| SBI Securities Co., Ltd. | 45,537 | $57.8K | 0.00% | +2,058+4.7% | Added |
| Dimensional Fund Advisors LP | 66,215 | $83.4K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 71,506 | $90.1K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 72,897 | $91.8K | 0.00% | +72,897 | New |
| Bridgeway Capital Management, LLC | 76,031 | $95.8K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 88,615 | $112.5K | 0.00% | −19,385−17.9% | Reduced |
| Bank of America Corp | 91,462 | $116.2K | 0.00% | −2,990−3.2% | Reduced |
| Bank of New York Mellon Corp | 96,174 | $122.1K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 122,879 | $154.8K | 0.00% | −127,464−50.9% | Reduced |
| Northern Trust Corp | 134,743 | $171.1K | 0.00% | −4,995−3.6% | Reduced |
| State Street Corp | 174,598 | $220.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 192,500 | $244.5K | 0.00% | +13,800+7.7% | Added |
| UBS Group AG | 222,267 | $282.3K | 0.00% | +670.0% | Added |
| Geode Capital Management, LLC | 529,702 | $667.6K | 0.00% | +3,810+0.7% | Added |
| Citigroup Inc | 594,057 | $748.5K | 0.00% | +2,100+0.4% | Added |
| Vanguard Group Inc | 700,385 | $882.5K | 0.00% | +13,808+2.0% | Added |
| BlackRock, Inc. | 698,967 | $887.7K | 0.00% | +3,252+0.5% | Added |
| Essex Woodlands Management, Inc. | 1,105,941 | $1.40M | 0.46% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −412−100.0% | Sold out |